SCHEMBL35211441

SCHEMBL35211441

CC(C)(C)N1CC(F)(CN)C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21341816 0.78 CRHBP (0.34) CRHBPCRHR2
SCHEMBL12458814 0.77 GRIN2D (0.41)
SCHEMBL15716234 0.76 CRHBP (0.33) CRHBPCRHR2
SCHEMBL14805863 0.73 CRHBP (0.34) CRHBPCRHR2
SCHEMBL16849087 0.72
SCHEMBL35211323 0.71 CRHBP (0.33) CRHBPCRHR2
SCHEMBL35211321 0.71 CRHBP (0.33) CRHBPCRHR2
SCHEMBL680047 0.71 CRHBP (0.39) CRHBPCRHR2
SCHEMBL12445299 0.71 CRHBP (0.39) CRHBPCRHR2
SCHEMBL12127018 0.69 CRHBP (0.38) CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125384-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125384-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF CGAS, GMPS, PRKG1 CRHBP 2395/4885CRHR2 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.